{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T06:28:27Z","timestamp":1793946507483,"version":"4.8.0"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["J Trauma Acute Care Surg"],"published-print":{"date-parts":[[2022,4]]},"abstract":"<jats:sec>\n            <jats:title>BACKGROUND<\/jats:title>\n            <jats:p>Platelet dysfunction is known to occur in patients with traumatic brain injury (TBI), and the correction of platelet dysfunction may prevent hemorrhagic progression in TBI. Thromboelastography with platelet mapping (TEG-PM; Haemonetics) evaluates the degree of platelet function inhibition through the adenosine diphosphate (ADP) and arachidonic acid (AA) pathways. We hypothesized that ADP and AA inhibition would improve with the transfusion of platelets in patients with TBI.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>METHODS<\/jats:title>\n            <jats:p>A retrospective review was conducted at a Level I trauma center of all patients presenting with TBI from December 2019 to December 2020. Per a practice management guideline, a platelet mapping assay was obtained on all patients with TBI upon admission. If ADP or AA was found to be inhibited (&gt;60%), the patient was transfused 1 unit of platelets and a repeat platelet mapping assay was ordered. Demographic data, laboratory values, and outcomes were analyzed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>RESULTS<\/jats:title>\n            <jats:p>Over the 13-month study period, 453 patients with TBI underwent TEG-PM with a protocol adherence rate of 66.5% resulting in a total of 147 patients who received platelets for ADP and\/or AA inhibition; of those, 107 underwent repeat TEG-PM after platelets were administered. With the administration of platelets, ADP (<jats:italic toggle=\"yes\">p<\/jats:italic> &lt; 0.0001), AA (<jats:italic toggle=\"yes\">p<\/jats:italic> &lt; 0.0001), and MA (<jats:italic toggle=\"yes\">p<\/jats:italic> = 0.0002) all significantly improved. Of 330 patients with TBI not taking antiplatelet medications, 50.9% showed inhibition in ADP and\/or AA. If AA or ADP inhibition was noted on admission, mortality was increased (<jats:italic toggle=\"yes\">p<\/jats:italic> = 0.0108). If ADP improved with platelet administration, the need for neurosurgical intervention was noted to decrease (<jats:italic toggle=\"yes\">p<\/jats:italic> = 0.0182).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSION<\/jats:title>\n            <jats:p>Patients with TBI and platelet inhibition may benefit from the administration of platelets to correct platelet dysfunction. Thromboelastography with platelet mapping may be implemented in the initial workup of patients presenting with TBI to assess platelet dysfunction and provide prognostic information, which may guide treatment.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>LEVEL OF EVIDENCE<\/jats:title>\n            <jats:p>Therapeutic \/ Care Management, level III.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/ta.0000000000003516","type":"journal-article","created":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T17:00:23Z","timestamp":1648054823000},"page":"701-707","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":19,"title":["Traumatic brain injury patients with platelet inhibition receiving platelet transfusion demonstrate decreased need for neurosurgical intervention and decreased mortality"],"prefix":"10.1097","volume":"92","author":[{"given":"M. Victoria P.","family":"Miles","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Chace","family":"Hicks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hunter","family":"Parmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abigail","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lani","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Maxwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"bib1-20250806","article-title":"Surveillance report of traumatic brain injury-related hospitalizations and deaths by age group, sex, and mechanism of injury\u2014United States, 2016 and 2017 [Internet]","year":"2021","journal-title":"2021 []"},{"issue":"6","key":"bib2-20250806","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1097\/00001199-199912000-00009","article-title":"Traumatic brain injury in the United States: a public health perspective","volume":"14","year":"1999","journal-title":"J Head Trauma Rehabil"},{"key":"bib3-20250806","first-page":"748","article-title":"The coagulopathy of trauma: a review of mechanisms","volume":"65","year":"2008","journal-title":"J Trauma"},{"issue":"2","key":"bib4-20250806","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.jss.2014.08.016","article-title":"Platelet dysfunction and platelet transfusion in traumatic brain injury","volume":"193","year":"2015","journal-title":"J Surg Res"},{"key":"bib5-20250806","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1097\/TA.0000000000000216","article-title":"Traumatic brain injury causes platelet adenosine diphosphate and arachidonic acid receptor inhibition independent of hemorrhagic shock in humans and rats","volume":"76","year":"2014","journal-title":"J Trauma Acute Care"},{"issue":"13\u201314","key":"bib6-20250806","first-page":"1849","article-title":"Effects of platelet dysfunction and platelet transfusion on outcomes in traumatic brain injury patients","volume":"32","year":"2018","journal-title":"Brain Inj"},{"issue":"5","key":"bib7-20250806","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.jamcollsurg.2012.01.050","article-title":"Early platelet dysfunction: an unrecognized role in the acute coagulopathy of trauma","volume":"214","year":"2012","journal-title":"J Am Coll Surg"},{"key":"bib8-20250806","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/S1474-4422(17)30197-7","article-title":"Coagulopathy and haemorrhagic progression in traumatic brain injury: advances in mechanisms, diagnosis, and management","volume":"16","year":"2017","journal-title":"Lancet Neurol"},{"issue":"19","key":"bib9-20250806","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1089\/neu.2013.3302","article-title":"Systemic platelet dysfunction is the result of local dysregulated coagulation and platelet activation in the brain in a rat model of isolated traumatic brain injury","volume":"31","year":"2014","journal-title":"J Neurotrauma"},{"issue":"5","key":"bib10-20250806","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1097\/TA.0b013e31828c7a6b","article-title":"Platelet activation and dysfunction in a large-animal model of traumatic brain injury and hemorrhage","volume":"74","year":"2013","journal-title":"J Trauma Acute Care Surg"},{"issue":"6","key":"bib11-20250806","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/j.amjsurg.2019.09.024","article-title":"Platelet dysfunction on thromboelastogram is associated with severity of blunt traumatic brain injury","volume":"218","year":"2019","journal-title":"Am J Surg"},{"issue":"2","key":"bib12-20250806","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s12028-012-9745-6","article-title":"Platelet dysfunction is an early marker for traumatic brain injury-induced coagulopathy","volume":"18","year":"2013","journal-title":"Neurocrit Care"},{"issue":"4","key":"bib13-20250806","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1089\/neu.2013.3089","article-title":"Early platelet dysfunction in a rodent model of blunt traumatic brain injury reflects the acute traumatic coagulopathy found in humans","volume":"31","year":"2014","journal-title":"J Neurotrauma"},{"issue":"1","key":"bib14-20250806","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/TA.0b013e3182a9cc95","article-title":"Acquired coagulopathy of traumatic brain injury defined by routine laboratory tests: which laboratory values matter?","volume":"76","year":"2014","journal-title":"J Trauma Acute Care Surg"},{"issue":"4","key":"bib15-20250806","first-page":"881","article-title":"The impact of platelets on the progression of traumatic intracranial hemorrhage","volume":"68","year":"2010","journal-title":"J Trauma"},{"key":"bib16-20250806","doi-asserted-by":"crossref","first-page":"954","DOI":"10.2174\/1389450117666160310153211","article-title":"Targeted thromboelastographic (TEG) blood component and pharmacologic hemostatic therapy in traumatic and acquired coagulopathy","volume":"17","year":"2016","journal-title":"Curr Drug Targets"},{"issue":"1","key":"bib17-20250806","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s00068-016-0643-z","article-title":"Adenosine diphosphate platelet dysfunction on thromboelastogram is independently associated with increased morality in traumatic brain injury","volume":"43","year":"2017","journal-title":"Eur J Trauma Emerg Surg"},{"key":"bib18-20250806","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1097\/TA.0000000000002047","article-title":"Goal-directed platelet transfusions correct platelet dysfunction and may improve survival in patients with severe traumatic brain injury","volume":"85","year":"2018","journal-title":"J Trauma Acute Care Surg"},{"key":"bib19-20250806","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1097\/CCM.0000000000004348","article-title":"Early administration of desmopressin and platelet transfusion for reducing hematoma expansion in patients with acute antiplatelet therapy associated intracerebral hemorrhage","volume":"48","year":"2020","journal-title":"Crit Care Med"},{"issue":"3","key":"bib20-20250806","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1080\/02699052.2018.1425804","article-title":"Platelet transfusion does not improve outcomes in patients with brain injury on antiplatelet therapy","volume":"32","year":"2018","journal-title":"Brain Inj"},{"issue":"3","key":"bib21-20250806","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.jtcvs.2004.02.019","article-title":"Clopidogrel and bleeding in patients undergoing elective coronary artery bypass grafting","volume":"128","year":"2004","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"1","key":"bib22-20250806","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s00701-015-2645-8","article-title":"High prevalence of pharmacologically induced platelet dysfunction in the acute setting of brain injury","volume":"158","year":"2016","journal-title":"Acta Neurochir"},{"issue":"Suppl 1","key":"bib23-20250806","first-page":"28S","article-title":"Coagulopathy after traumatic brain injury: Incidence, pathogenesis, and treatment options","volume":"53","year":"2013","journal-title":"Transfusion"},{"issue":"1","key":"bib24-20250806","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/TA.0b013e318256deab","article-title":"Characterization of platelet dysfunction after trauma","volume":"73","year":"2012","journal-title":"J Trauma Acute Care Surg"},{"issue":"6","key":"bib25-20250806","first-page":"1410","article-title":"Early coagulopathy after isolated severe traumatic brain injury: relationship with hypoperfusion challenged","volume":"69","year":"2010","journal-title":"J Trauma"},{"issue":"9","key":"bib26-20250806","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.injury.2010.04.019","article-title":"Time course of coagulopathy in isolated severe traumatic brain injury","volume":"41","year":"2010","journal-title":"Injury"},{"issue":"1","key":"bib27-20250806","first-page":"55","article-title":"Coagulopathy in severe traumatic brain injury: a prospective study","volume":"66","year":"2009","journal-title":"J Trauma"},{"issue":"2","key":"bib28-20250806","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0002-9343(80)90383-6","article-title":"Acquired dysfunction due to the circulation of \u201cexhausted\u201d platelets","volume":"69","year":"1980","journal-title":"Am J Med"},{"issue":"8","key":"bib29-20250806","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.1161\/STROKEAHA.109.555433","article-title":"Tissue factor in brain is not saturated with factor VIIa: Implications for factor VIIa dosing in intracerebral hemorrhage","volume":"40","year":"2009","journal-title":"Stroke"},{"issue":"4","key":"bib30-20250806","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1097\/00005373-200110000-00003","article-title":"Platelet activation and function after trauma","volume":"51","year":"2001","journal-title":"J Trauma"},{"issue":"5","key":"bib31-20250806","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1097\/TA.0000000000002820","article-title":"Dynamic effects of calcium on in vivo and ex vivo platelet behavior after trauma","volume":"89","year":"2020","journal-title":"J Trauma Acute Care Surg"},{"issue":"1","key":"bib32-20250806","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1097\/TA.0000000000002521","article-title":"Desmopressin is a transfusion sparing option to reverse platelet dysfunction in patients with severe traumatic brain injury","volume":"88","year":"2020","journal-title":"J Trauma Acute Care Surg"},{"issue":"12","key":"bib33-20250806","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1097\/CCM.0000000000004021","article-title":"Retrospective assessment of desmopressin effectiveness and safety in patients with antiplatelet-associated intracranial hemorrhage*","volume":"47","year":"2019","journal-title":"Crit Care Med"}],"container-title":["Journal of Trauma and Acute Care Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TA.0000000000003516","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T16:13:33Z","timestamp":1754496813000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TA.0000000000003516"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/ta.0000000000003516","relation":{},"ISSN":["2163-0763","2163-0755"],"issn-type":[{"value":"2163-0763","type":"electronic"},{"value":"2163-0755","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]}}}